A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in...

Clinical Cancer Research 2010 / 04 Vol. 16; Iss. 8

A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Haura, E. B., Ricart, A. D., Larson, T. G., Stella, P. J., Bazhenova, L., Miller, V. A., Cohen, R. B., Eisenberg, P. D., Selaru, P., Wilner, K. D., Gadgeel, S. M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-09-1920
Date:
April, 2010
File:
PDF, 241 KB
english, 2010
Conversion to is in progress
Conversion to is failed